Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02339506 · ClinicalTrials.gov registry record · NA

Stress and the Nervous System

A NA study of Stress, Physiological and Autonomic Nervous System, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02339506 is a NA study of Stress, Physiological and Autonomic Nervous System that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 23 participants, below the 351-participant average among 9 other Stress, Physiological trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02339506, a NA study of Stress, Physiological and Autonomic Nervous System, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Models of stress such as hypoglycemia have identified that stress results the next day in decreased baroreflex sensitivity. This project will test the hypothesis that these delayed changes in autonomic nervous system function are secondary to a rise in ACTH. The investigators will infuse cosyntropin versus placebo in a double-blind, crossover study in healthy adults and measure the delayed effects on the autonomic system as measured by cardiovagal baroreflex sensitivity.

Interventions

  • DRUG Placebo
  • DRUG Cosyntropin

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2015-04
Est. Completion 2020-11
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT02339506

The ClinicalTrials.gov registry entry for NCT02339506 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 9 other Stress, Physiological trials with a reported enrollment target (93% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stress, Physiological appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02339506 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02339506 about?

NCT02339506 is a clinical study titled "Stress and the Nervous System". Models of stress such as hypoglycemia have identified that stress results the next day in decreased baroreflex sensitivity. This project will test the hypothesis that these delayed changes in autonomic nervous system function are secondary to a rise in ACTH. The investigators will infuse cosyntropin...

What is the current status of trial NCT02339506?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-04. Estimated completion is 2020-11.

What conditions does trial NCT02339506 study?

This clinical trial studies the following conditions: Stress, Physiological, Autonomic Nervous System, Baroreflex.

What interventions are being tested in trial NCT02339506?

The interventions under investigation include: Placebo (DRUG), Cosyntropin (DRUG).

Who is sponsoring clinical trial NCT02339506?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02339506 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress, Physiological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.